About: Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) 1998 ഫെബ്രുവരി 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) artículu científicu espublizáu en febreru de 1998 (ast) artikull shkencor i botuar më 01 shkurt 1998 (sq) scientific article published on 01 February 1998 (en)
publication date	wds:Q74357144-67B7515E-E1D1-4364-9029-F7324E8B8B80
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74357144-582136F6-A149-4D55-AA15-15504A34E611 wds:Q74357144-6EBE739C-0A62-471F-BD27-4E22A80B1E34 wds:Q74357144-7024DAA6-5323-47EF-9876-4606DAB15FCC wds:Q74357144-CA1D9C64-BB9D-495B-BD6C-667F71D9AF1C wds:Q74357144-CACA7830-87AD-430D-B631-D34201C7A58B wds:Q74357144-D54803E5-3C8F-412D-AD6A-B88AEDFFD32D wds:Q74357144-E7FDE47D-1FCF-48D4-B95D-5DC9446ADE0E
author name string	G Döring F Ratjen A Bauernfeind B Przyklenk H von der Hardt G Steinkamp H G Wiesemann
rdfs:label	Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (en) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (nl) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (sq)
skos:prefLabel	Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (en) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (nl) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (sq)
name	Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (en) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (nl) Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (sq)
title	wds:Q74357144-4E2BA0BC-DB55-4582-81D2-4F2F4CC27389
title	Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis (en)
page(s)	wds:Q74357144-6D747BC3-1BD4-4FAE-AC56-1C1EC79098DE
page(s)	88-92
instance of	wds:Q74357144-79BEAC94-511B-46AE-9DBC-189500B76F48
instance of	scholarly article
main subject	wds:Q74357144-2FDF78B7-8F78-4BC6-AF71-A90F4F19EA4E wds:Q74357144-60A4F4BA-820A-4B4B-AC4A-18B05A1E4953 wds:Q74357144-FF2D2768-5020-497C-9B33-8DBE4C8866EA
main subject	placebo Pseudomonas aeruginosa cystic fibrosis
PubMed ID	wds:Q74357144-CA229C91-A248-4DA8-93DF-F7F8F1D9AD02
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9516091
PubMed ID	9516091
published in	wds:Q74357144-FD9D0C51-F953-4BE2-8AEF-1C78C3004D05
published in	Pediatric Pulmonology
issue	wds:Q74357144-6B5D928E-D4AF-420B-A536-1B4044A4FF34
volume	wds:Q74357144-5BE7711F-4AD7-47CC-A70E-DEC159CBA24C
issue	2
volume	25
DOI	wds:Q74357144-EF642DBE-7110-4425-B81E-11F1676C0AC2
DOI	http://dx.doi.org/10.1002/(SICI)1099-0496(199802)25:2%3C88::AID-PPUL3%3E3.0.CO;2-J
DOI	10.1002/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74357144
is cites work of	Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis Cystic fibrosis Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management Vaccines and immunotherapy against Pseudomonas aeruginosa Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections Exacerbations in cystic fibrosis: 2 . prevention. Breath sulfides and pulmonary function in cystic fibrosis Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study' Early lung disease in cystic fibrosis Inhaled antibiotics for long-term therapy in cystic fibrosis Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis Lung infections associated with cystic fibrosis Inhaled anti-infective agents: emphasis on colistin Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis Update and Review: Cystic Fibrosis Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis [Inhaled antibiotic therapy in cystic fibrosis] Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review. Nebulised anti-pseudomonal antibiotics for cystic fibrosis Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software